HG-7-85-01
HG-7-85-01 is a potent ATP-competitive, type II inhibitor targeting BCR-ABL (including T315I mutant), PDGFRα, Kit, and Src kinases. It demonstrates robust anti-proliferative activity in vitro, inducing cell cycle arrest and apoptosis in leukemia cell lines, and has shown efficacy in preclinical in vivo models of BCR-ABL-driven cancers.
Product Specifications
CAS Number
1258391-13-7
Product Name Alternative
HG78501, HG-7-85-01, HG 7 85 01
Field of Research
Cardiovascular Research, Cell Biology, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.08% (May vary between batches)
Solubility
DMSO:100 mg/mL (164.29 mM)
Smiles
O=C (NC1=CC=C (C (=C1) C (F) (F) F) CN2CCN (CC) CC2) C3=CC=CC (=C3) C4=NC=5SC (=NC5C=C4) NC (=O) C6CC6
Molecular Formula
C31H31F3N6O2S
Molecular Weight
608.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
